Influenza Vaccination in the Emergency Department
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Randomized controlled trial of influenza vaccination versus referral for vaccination in the Emergency department. Is the Emergency Department an effective venue for vaccination for influenza? Does vaccination for influenza in the Emergency Department change the rates of influenza, influenza-like-illness or medical provider visits when compared with patient referred for vaccination in the community?
| Condition | Intervention |
|---|---|
|
Influenza |
Drug: Influenza Vaccination Behavioral: Education and referral |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Influenza Vaccination in the Emergency Department |
- Vaccination status [ Time Frame: 4 months ] [ Designated as safety issue: No ]
- Influenza rate [ Time Frame: 4 months ] [ Designated as safety issue: No ]
- Influenza-like illness rate [ Time Frame: 4 months ] [ Designated as safety issue: No ]
- Visits to medical providers [ Time Frame: 4 months ] [ Designated as safety issue: No ]
| Enrollment: | 140 |
| Study Start Date: | November 2007 |
| Study Completion Date: | April 2008 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Vaccination group
Vaccination group
|
Drug: Influenza Vaccination
0.5 mL Sanofi-Pasteur intramuscular influenza vaccination
|
|
Experimental: Education/referral
Education/referral
|
Behavioral: Education and referral
Patients are given information regarding the inactivated influenza vaccination and a list of community providers who provide influenza vaccination
|
Detailed Description:
This study is a prospective randomized, controlled trial of influenza vaccination vs referral for influenza vaccination in the Emergency Department. Subjects are either offered vaccination or education regarding vaccination and a list of community providers. At a four-month follow up, rates of influenza, influenza-like illness and number of medical provider visits are determined.
Eligibility| Ages Eligible for Study: | 6 Months and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Unvaccinated patients presenting to the Emergency Department aged 6 months or more who have at least one high risk attribute:
- Age 6-59 months or >50 years
- Pregnant
- Health care worker
- Aged 6 months-18 years on chronic aspirin therapy
- Comorbidity (cardiovascular disease, pulmonary disease, metabolic disease, renal disease, hepatic disease, seizures, neuromuscular disease, cognitive dysfunction, or any reason to have had regular medical follow up or hospitalization in the preceding year)
- Household contact or caregiver of someone with at least one high risk attribute
Exclusion Criteria:
- Prior vaccination
- History of Guillan-Barre syndrome within 6 weeks of prior influenza vaccination
- Allergy to influenza vaccination or eggs
- Age < 6 months old
- Fever with more than minor illness
- Hospitalization
Contacts and Locations| United States, Arizona | |
| University of Arizona | |
| Tucson, Arizona, United States, 85724 | |
| Principal Investigator: | Katherine M Hiller, MD | University of Arizona Department of Emergency Medicine |
More Information
No publications provided
| Responsible Party: | Katherine M Hiller, MD, Department of Emergency Medicine |
| ClinicalTrials.gov Identifier: | NCT00822627 History of Changes |
| Other Study ID Numbers: | 1 |
| Study First Received: | January 12, 2009 |
| Last Updated: | January 13, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Arizona:
|
Influenza vaccination Emergency Department |
Additional relevant MeSH terms:
|
Emergencies Influenza, Human Disease Attributes Pathologic Processes Orthomyxoviridae Infections |
RNA Virus Infections Virus Diseases Respiratory Tract Infections Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 17, 2013